Skip to main content
Medical information Clinical review pending

Genetic Testing

FREM2 Gene Fraser Syndrome Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to detect mutations in the FREM2 gene associated with Fraser syndrome, a rare developmental disorder. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card. Confirm with the laboratory before booking.
Results
Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
A clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected by Fraser syndrome are required prior to testing. Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the FREM2 Gene Fraser Syndrome Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected Fraser syndrome based on clinical features.
  • ✓Family history of Fraser syndrome.
  • ✓Presence of congenital malformations suggestive of the syndrome.
  • ✓Genetic counseling for individuals with a family history of related disorders.
  • ✓Prenatal diagnosis in high-risk pregnancies.
02

In plain language

What this test helps you understand

Identifies mutations in the FREM2 gene associated with Fraser syndrome, aiding in diagnosis, prognosis, and genetic counseling for affected individuals and families.
The FREM2 Gene Fraser Syndrome NGS Genetic DNA Test is a diagnostic tool that uses Next-Generation Sequencing (NGS) technology to identify mutations in the FREM2 gene. Mutations in this gene are linked to Fraser syndrome, a rare genetic condition affecting development and causing various physical anomalies. This test helps in understanding the genetic basis of the condition.

This test specifically analyzes the FREM2 gene, which is important for the proper development of the body's structures. Identifying mutations can provide crucial information for diagnosis and management.

Individuals or families with a history of Fraser syndrome or related developmental abnormalities may benefit from this test. Symptoms can vary but may include physical development issues and congenital malformations.

Early diagnosis through genetic testing can lead to timely interventions and improved health outcomes. It also aids in informed family planning and connects individuals with appropriate care and resources.

After receiving your results, a genetic counselor will help explain the findings and their implications for you and your family.

To proceed with the test, a clinical history and genetic counseling session, including a family pedigree chart, are required. We offer convenient sample collection options, including home visits, and have branches in major cities like Nairobi and Mombasa. Contact us at +254711564616 to book your test.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected by Fraser syndrome are required prior to testing. Confirm with the laboratory before booking.
SampleBlood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card. Confirm with the laboratory before booking.
MethodologyNext-Generation Sequencing (NGS) is used to analyze the FREM2 gene for mutations.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test only analyzes the FREM2 gene. Fraser syndrome can sometimes be caused by mutations in other genes. The test may not detect all possible mutations within the FREM2 gene. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Fraser syndrome is a rare genetic disorder characterized by a range of developmental anomalies, including physical abnormalities and congenital malformations.
Individuals or families with a history of Fraser syndrome or related developmental abnormalities should consider this test.
The test involves analyzing a sample of your DNA (usually from blood) to look for specific mutations in the FREM2 gene using Next-Generation Sequencing (NGS).
Results are typically available within 3 to 4 weeks, but this can vary. Confirm with the laboratory before booking.
A genetic counselor will discuss your results with you, explaining what they mean for you and your family, and discussing any potential next steps.
Yes, a genetic counseling session and clinical history are required before testing to ensure the test is appropriate and to help interpret the results.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp